Home
Transactions

Work Area: Transactions

Your guide to synthetic drug royalty dealmaking

Selling revenue streams is an increasingly important way of monetising pharma innovations

Five key patent transactions takeaways

An over-arching theme during an IAM event was the key importance of relationships, trust and empathy between parties when deals are getting done

WiLAN revenues plummet in Q3 on prior year but Micron deal excluded

Strategic review of the licensing business nears a year in motion with no news on potential divestment announced

Latest content

Revealed: first Chinese target of ZTE's new SEP licensing push

Court documents show that ZTE has filed a patent suit against Tinno Mobile, the Shenzhen-based company that owns French smartphone brand Wiko

08 December 2021

IP leaders weigh in on what makes or breaks a patent pool

From the need for clarity to the problems of self-certification, top practitioners give their prescriptions for making the most of the pool model

07 December 2021

Hyundai – auto’s quiet patent superpower

The automaker and its affiliates are growing their portfolios in technologies that will be critical for developing the car of the future

06 December 2021

CAFC tees up patent fight over multi-billion-dollar Moderna covid revenues

Arbutus Biopharma’s shares soar in anticipation of mRNA jab royalty lawsuit after Federal Circuit ruling

03 December 2021

Data monetisation drives Sanofi’s $180 million investment in AI biotech Owkin

The deal shows how privacy and silo barriers to the commercialisation of information are being overcome

29 November 2021

Latest patent sale by Chinese lab shows hot demand for 5G assets

Research outfit Shanghai Langbo has found customers among both operating companies and licensing firms for its recent patent output

25 November 2021

Hyundai Motor bolsters portfolio in patent assignment deal with AT&T

Korean automaker acquires dozens of assets in areas including drone technology and speech processing

24 November 2021

Novo Nordisk’s $3.3 billion Dicerna purchase shows booming RNA IP market

Danish company makes its biggest-ever acquisition in an area where demand for assets is growing rapidly

23 November 2021

The IP story to engage the c-suite is there, but it takes bravery to tell it

Saturday Opinion: After a highly successful IPBC in Seattle earlier this week, it is clear that there has never been a better time to take the value creation gospel to the boardroom

20 November 2021

Recent lawsuits show urgency of Peloton’s efforts to bulk up its patent portfolio

Maker of high-end exercise equipment sues two rivals just days after new patent grant – the company has used M&A and new filings to boost its holdings dramatically over the last year

19 November 2021

Unlock unlimited access to all IAM content